Last mentioned: Mar 19, 2026
CFO Appointment
Bambusa Therapeutics officially announces Todd James as the new Chief Financial Officer.
Industry Tenure
Todd James builds 20+ years of experience in biopharmaceutical leadership and finance.
Bambusa Therapeutics has appointed Todd James, a biopharmaceutical industry veteran with over 20 years of experience, as its new Chief Financial Officer. The strategic hire signals a focus on strengthening capital markets expertise and investor relations as the company advances its therapeutic pipeline.
This page surfaces every story mentioning Bambusa Therapeutics across our startup coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running startup beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Bambusa Therapeutics was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |